Equities

ZimVie Inc

ZimVie Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)13.74
  • Today's Change0.25 / 1.85%
  • Shares traded73.91k
  • 1 Year change+53.69%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

ZimVie Inc. is a global life sciences company in the dental market. The Company develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. The Company works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems. The key products in its dental implant systems portfolio include the T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, BellaTek Encode Impression System, and Puros Allograft Particulate. The Company markets its products in about 70 countries in North America, Europe, Latin America and Asia.

  • Revenue in USD (TTM)451.30m
  • Net income in USD-47.73m
  • Incorporated2021
  • Employees2.60k
  • Location
    ZimVie Inc10225 Westmoor DriveWESTMINSTER 80021United StatesUSA
  • Phone+1 (303) 443-7500
  • Websitehttps://www.zimvie.com/en
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Atlantic International Corp313.06m-68.07m260.76m7.00--14.53--0.8329-5.55-5.5512.450.3584.44--10.4844,723,330.00-96.45-71.97-233.48-106.0910.8161.01-21.74-1,471.82---1.640.8328---100.00---37.43------
AngioDynamics, Inc.292.73m-243.03m273.87m748.00--1.41--0.9356-6.04-6.047.254.790.74342.276.55391,344.90-61.72-16.38-74.39-18.7051.7152.95-83.02-30.491.41--0.00---10.282.35-251.53--13.09--
Neuropace Inc76.45m-28.09m274.30m171.00--27.86--3.59-0.9924-0.99242.700.32990.78171.836.69447,087.70-28.72---33.44--73.83---36.74--4.77-4.060.8578--43.72--30.00------
OraSure Technologies, Inc.224.26m11.37m284.20m638.0025.300.667811.611.270.15060.15063.015.710.48622.645.58351,509.402.720.72382.940.821242.2646.945.591.1311.20--0.00040.004.6417.41413.1782.2010.18--
Clearpoint Neuro Inc30.43m-18.15m302.33m107.00--10.43--9.94-0.6912-0.69121.161.050.72421.509.66284,383.20-43.19-34.75-51.20-39.6760.3864.75-59.64-76.913.61--0.00--16.5626.64-34.40--75.30--
Delcath Systems Inc22.64m-34.12m307.91m76.00--31.48--13.60-1.36-1.360.83430.30590.57140.90946.34297,947.40-86.11-116.57-156.17-243.2181.3171.02-150.70-1,235.371.03-172.600.1892---24.05-9.53-30.60---5.26--
Cerus Corp197.91m-19.73m308.29m288.00--5.76--1.56-0.1076-0.10761.080.28821.001.977.88687,194.40-10.01-25.99-15.26-40.6260.5261.90-10.00-35.811.92-1.190.6057---0.806119.6912.37--32.07--
CVRx Inc47.26m-58.48m328.04m200.00--5.02--6.94-2.71-2.712.192.690.40380.6576.14236,275.00-49.96---54.21--84.16---123.75--10.23-17.040.4302--74.89--0.5528------
Nano-X Imaging Ltd10.13m-57.47m344.55m164.00--1.97--34.02-0.9974-0.99740.17552.990.0482--6.8961,756.10-27.33-30.98-29.96-35.10-81.80---567.41-1,527.245.09--0.0181--15.47--46.33--114.35--
MaxCyte Inc45.60m-35.74m368.13m143.00--1.72--8.07-0.3420-0.34200.43682.030.1770.55767.17318,878.30-13.87-13.18-14.86-14.3385.9888.79-78.37-62.969.22--0.00---6.7219.89-60.89--39.13--
ZimVie Inc451.30m-47.73m372.31m2.60k--0.9152--0.825-1.77-13.1616.6014.740.3941.144.04173,575.00-4.17---4.81--63.1865.51-10.58-8.731.38-0.62640.3514---1.26-16.08-19.50---23.70--
Tactile Systems Technology Inc285.05m15.45m373.39m992.0024.201.8016.861.310.6430.64311.918.660.98126.206.80287,349.805.320.90156.201.0951.4449.105.420.83093.80--0.11460.0011.2013.81259.6033.91-23.62--
Alpha Teknova Inc36.35m-31.68m412.57m210.00--4.73--11.35-0.7366-0.73660.8341.640.27703.127.44173,081.00-24.14---25.92--17.71---87.17--3.94-75.860.133---11.43--22.52------
Quanterix Corp129.33m-39.71m422.94m441.00--1.26--3.27-1.04-1.043.408.770.30782.374.60293,265.30-9.45-15.96-10.30-17.6657.4252.79-30.71-53.798.99--0.00--15.9626.6066.56--20.07--
Semler Scientific Inc58.94m15.91m430.67m92.0028.924.9426.027.312.052.057.5811.990.686817.209.33640,619.6018.5438.8320.3744.4188.0590.2227.0032.583.09--0.00--20.2825.9843.6932.64-0.3821--
Pacific Biosciences of California Inc173.15m-394.24m468.75m796.00--1.04--2.71-1.46-1.460.641.650.10341.975.78217,521.40-23.55-16.19-25.40-17.8123.8137.35-227.69-136.218.64-21.870.6634--56.2920.592.39--36.68--
Data as of Nov 21 2024. Currency figures normalised to ZimVie Inc's reporting currency: US Dollar USD

Institutional shareholders

52.62%Per cent of shares held by top holders
HolderShares% Held
Camber Capital Management LPas of 30 Sep 20242.73m9.88%
Eversept Partners LPas of 30 Sep 20242.07m7.51%
BlackRock Fund Advisorsas of 30 Sep 20241.76m6.39%
The Vanguard Group, Inc.as of 30 Sep 20241.75m6.33%
Neuberger Berman Investment Advisers LLCas of 30 Sep 20241.37m4.98%
Kent Lake Capital LLCas of 30 Jun 20241.25m4.53%
Dimensional Fund Advisors LPas of 30 Sep 20241.07m3.88%
Morgan Stanley & Co. LLCas of 30 Sep 20241.00m3.64%
Citadel Advisors LLCas of 30 Sep 2024759.78k2.76%
Kent Lake Pr LLCas of 30 Sep 2024750.00k2.72%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.